Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated Europe Genomic Cancer Panel and Profiling Market size by value at USD 2.62 billion in 2023. During ...
, as defined by the Food and Drug Administration (FDA), can serve diagnostic, prognostic, predictive, and pharmacodynamics purposes in cancer and other diseases. Diagnostic biomarkers are ...
Next-generation sequencing (NGS) was developed at the turn of the millennium, and the first complete sequence of the human genome was achieved in 2022. Recent technological developments now allow us ...
The presentation "Measurable Residual Disease in AML using Oncomine NGS analysis" by Dr. Jong-Mi Lee from the College of Medicine at The Catholic University of Korea explores the application of ...
IGHV status significantly influences CLL prognosis, with mutated IGHV linked to longer survival and unmutated IGHV to shorter progression-free survival. NGS enhances IGHV analysis by overcoming Sanger ...
Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Treated With Cyclin-Dependent Kinase ...
A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short ...
Azenta Life Sciences offers a range of low binding consumables that deliver consistent performance from sensitive applications that require low DNA input such as Next Generation Sequencing (NGS). As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results